창신화학

비상장계속사업자

changshinchem

배상도

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

창신화학

Business Reg. No. 4178104620 · CEO 배상도

I.Investment Overview

Target창신화학 (4178104620)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명창신화학
영문명changshinchem
대표자배상도
사업자등록번호4178104620
법인등록번호2062110001219
설립일1989.12.12
종업원수49명

V.Workforce

49

Current headcount · 2026.07 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW312.72021324.72022378.9202342820244752025
영업이익100M KRW41.4202136.1202243.1202335.1202419.42025
순이익100M KRW34.6202132.1202235.9202353.2202429.72025
Item20252024202320222021
자산총계717.9억원708.6억원604.9억원390.7억원390억원
부채총계364.3억원384.7억원334.3억원155.9억원190억원
자본총계353.6억원323.9억원270.7억원234.8억원200억원
매출액475억원428억원378.9억원324.7억원312.7억원
영업이익19.4억원35.1억원43.1억원36.1억원41.4억원
순이익29.7억원53.2억원35.9억원32.1억원34.6억원

VII.Financial Ratios

FY2025 basis

4.07%

영업이익률

6.26%

순이익률

4.14%

ROA

8.41%

ROE

103.02%

부채비율

49.26%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

창신화학 투심보고서 | Alpha Lenz